Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial

Abstract Background Optimal management strategies for clinically localised prostate cancer are debated. Using median 10-year data from the largest randomised controlled trial to date (ProtecT), the lifetime cost-effectiveness of three major treatments (radical radiotherapy, radical prostatectomy and...

Full description

Bibliographic Details
Main Authors: S. Sanghera, S. Mohiuddin, J. Coast, K. Garfield, S. Noble, C. Metcalfe, J. A. Lane, E. L. Turner, D. Neal, F. C. Hamdy, R. M. Martin, J. L. Donovan, for the ProtecT study group
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Cancer
Subjects:
Prostate cancer
ProtecT trial
Lifetime cost-effectiveness
Active monitoring
Radiotherapy
Prostatectomy
Online Access:http://link.springer.com/article/10.1186/s12885-020-07276-4

Similar Items

Similar Items